Multiplex Immunoassay Market: By Type (Bead-Based, Planar Based), By Technique (Protein Microarray, Antibody Microarray, DNA Microarray, Fluorescent Bead Microarray), By Product (Kits & Reagents, Instruments, Software), and Geography  

Multiplex Immunoassay Market size was valued at USD 3.3 billion in 2022 and is expected to reach USD 5.4 billion by 2028, at a CAGR of 7.1% from 2023-29. Owing introduction of newer technological advancements that have allowed for more robust multiplex assays in the detection of complex diseases and monitoring dozens of proteins at once, thereby optimizing clinical research and aiding in the discovery of new therapeutic options and multiplex assays can enable the researchers to receive more data from a sample when compared to singleplex such as ELISA or western blot and is a faster procedure and also saves both the time and cost are expected to fuel the growth of multiplex immunoassay market.  Moreover, increasing research activities and the rising prevalence of chronic diseases coupled with the increase in the number of pharmaceutical and biopharmaceutical companies are expected to propel the growth of the market. However, the requirement for specialized equipment and validated antibody pairs for multiplex immunoassay hampers the growth of the market over future years.